Sentante Launches Endovascular Robotic Platform in Europe

The system distinguishes itself through a 1:1 motion-mimicking interface that allows surgeons to operate using standard catheters and guidewires without specialized retraining. By integrating directly into existing cath-lab infrastructure, the technology captures high-fidelity procedural data—including drive-side force and torque sensing—during routine clinical work. This data serves as the foundation for the firm’s physical AI, which aims to provide increasingly autonomous assistance as the dataset matures.

CEO Edvardas Satkauskas noted that the platform’s value is locked into daily clinical volume, where real-world procedural signatures enable the system to learn from expert execution. Following a year of successful validation, including remote transatlantic procedures on cadaver models, the company is using these initial specialties as a proving ground. The safety logic and force-sensing maneuvers refined in peripheral interventions provide a direct pathway for future expansion into more complex neurovascular applications, complementing the company's existing FDA Breakthrough Device Designation for remote stroke treatment.